Marinus Pharma Balance Sheet - Annual (NASDAQ:MRNS)

Add to My Stocks
$8.78 $0.72 (8.93%) MRNS stock closing price Sep 21, 2018 (Closing)

A balance sheet is one of the three key financial statements released by a publicly listed company like Marinus Pharma, and helps in stock analysis. Financial strength can be guaged by performing Marinus Pharma stock analysis and by analyzing the balance sheet. Annual results announcements include the release of all three financial statements, of which the balance sheet is one. Apart from analyzing Marinus Pharma revenue Marinus Pharma operating cash flow, one needs to check balance sheet items like cash, fixed assets and debt. The Marinus Pharma balance sheet for 2017 shows cash on hand of $33.53M. The company has a debt to equity ratio of .

View latest 10 year balance sheet data to check Marinus Pharma financial performance.
show more
Quarterly
Annual
View Previous Years
View Next Years
Fiscal year is Jan - Dec201720162015201420132012
Cash33.53M26.17M51.72M49.72M10.03M8.63M
Marketable Securities19.86M3.92M4.47M---
Receivables------
Inventory------
Raw Materials------
Work In Progress------
Finished Goods------
Notes Receivable------
Other Current Assets--1.57M-1.76M-
Total Current Assets
54.37M30.29M57.76M50.14M11.79M8.66M
Property Plant & Equipment1.82M1.5M----
Accumulated Depreciation------
Net Property Plant & Equipment
1.33M1.14M----
Investment & Advances4.96M-1.48M---
Other Non-Current Assets------
Deferred Charges------
Intangibles------
Deposits & Other Assets------
Total Assets
60.67M31.44M59.66M50.21M11.82M8.68M
Notes Payable-3.5M2.12M--2.67M
Accounts Payable-2.8M3.14M---
Current Portion Long-Term Debt------
Current Portion Capital Leases------
Accrued Expenses1.61M1.77M2.16M1.5M1.09M-
Income Taxes Payable------
Other Current Liabilities----1.19M1.34M
Total Current Liabilities
2.54M8.08M7.43M2.03M2.36M4.49M
Mortgages------
Deferred Taxes/Income------
Convertible Debt------
Long-Term Debt-1.74M5.25M7M--
Non-Current Capital Leases------
Other Long-Term Liabilities------
Total Liabilities
2.66M9.96M12.74M9.05M2.36M4.49M
Minority Interest------
Preferred Stock----69.84M59.54M
Common Stock Net------
Capital Surplus202.79M147.28M144.08M113.47M1.12M-
Retained Earnings-144.72M-125.82M-97.18M-72.33M-61.5M-56.23M
Treasury Stock------
Other Liabilities-0.09M-----
Shareholders Equity58M21.47M46.92M41.15M9.45M4.18M
Total Liabilities & Shareholders Equity60.67M31.44M59.66M50.21M11.82M8.68M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Looking at Marinus Pharma historical stock prices and the current Marinus Pharma stock price can tell you how the stock price has moved, whereas the Marinus Pharma PE ratio chart shows if its shares are overpriced in comparison to peers. The important things to look for in a balance sheet are:

  • Assets: Anything that the Marinus Pharma company owns and is a part of its books. Assets can be of three types: fixed, current and other assets which includes intangibles, advances. Internet companies typically don't have a lot of assets as there is not much investment in say machinery, equipment etc. Marinus Pharma had total assets of $60.67M.
  • Liabilities: The total liabilities of Marinus Pharma for the year 2017 total to $2.66M. Liabilities for a company like Marinus Pharma include bank loans, services which have been availed for which a settlement in the form of cash/ asset transfer needs to be done in future etc. A firm takes on such obligations to grow its business which in turn will generate future economic benefits for its business.

Marinus Pharma Balance Sheet - Key Ratios